
Zydus Lifesciences Limited has informed the Exchange regarding a press release dated July 07, 2023, titled "USFDA inspection at Zydus formulation manufacturing facility at SEZ 2, Ahmedabad concludes with nil observations".
Filed with NSE ·

Zydus Lifesciences Limited has informed the Exchange regarding a press release dated July 07, 2023, titled "USFDA inspection at Zydus formulation manufacturing facility at SEZ 2, Ahmedabad concludes with nil observations".
6ix hasn’t read this filing yet.
Zydus Lifesciences Limited on 6ix
Follow Zydus Lifesciences into a list and get an email when it puts out news.
Follow Zydus Lifesciences